ZEKTAYOS Trademark

Trademark Overview

On Friday, July 19, 2019, a trademark application was filed for ZEKTAYOS with the United States Patent and Trademark Office. The USPTO has given the ZEKTAYOS trademark a serial number of 88524058. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 28, 2023. This trademark is owned by Intercept Pharmaceuticals, Inc.. The ZEKTAYOS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, therapeutic bile acid analogues; pharmaceutical preparations for the treatment of liver diseases, disorders and conditions; pharmaceuticals for treating nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, liver fibrosis, and liver cirrhosis
zektayos

General Information

Serial Number88524058
Word MarkZEKTAYOS
Filing DateFriday, July 19, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 28, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 2, 2020

Trademark Statements

Description of MarkThe mark consists of the word "ZEKTAYOS" in all caps with a two-tone arc with six rays protruding from the top center of the arc and a round notch in the bottom center of the arc over the letters "YOS".
Goods and ServicesPharmaceutical preparations, namely, therapeutic bile acid analogues; pharmaceutical preparations for the treatment of liver diseases, disorders and conditions; pharmaceuticals for treating nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, liver fibrosis, and liver cirrhosis
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 29, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIntercept Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorristown, NJ 07960
Party NameIntercept Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10001

Trademark Events

Event DateEvent Description
Monday, August 28, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 28, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, February 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 7, 2023SOU EXTENSION 5 GRANTED
Wednesday, January 11, 2023SOU EXTENSION 5 FILED
Thursday, January 26, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 11, 2023SOU TEAS EXTENSION RECEIVED
Thursday, July 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 5, 2022SOU EXTENSION 4 GRANTED
Tuesday, July 5, 2022SOU EXTENSION 4 FILED
Tuesday, July 5, 2022SOU TEAS EXTENSION RECEIVED
Monday, March 21, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 21, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 21, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 21, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 21, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, January 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 6, 2022SOU EXTENSION 3 GRANTED
Thursday, January 6, 2022SOU EXTENSION 3 FILED
Thursday, January 6, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, July 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 16, 2021SOU EXTENSION 2 GRANTED
Friday, July 16, 2021SOU EXTENSION 2 FILED
Friday, July 16, 2021SOU TEAS EXTENSION RECEIVED
Thursday, July 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 13, 2021SOU EXTENSION 1 GRANTED
Wednesday, January 13, 2021SOU EXTENSION 1 FILED
Wednesday, January 13, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, July 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 2, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 2, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 13, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 27, 2020ASSIGNED TO LIE
Monday, April 20, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 26, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 26, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 26, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 11, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 11, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 3, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 3, 2019NON-FINAL ACTION E-MAILED
Thursday, October 3, 2019NON-FINAL ACTION WRITTEN
Thursday, September 26, 2019ASSIGNED TO EXAMINER
Tuesday, July 30, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, July 29, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 23, 2019NEW APPLICATION ENTERED

Related Keywords

zektayos liver pharmaceutical preparations nonalcoholic treating steatohepatitis fatty cirrhosis fibrosis disease